<DOC>
	<DOCNO>NCT01587339</DOCNO>
	<brief_summary>There number anti-epileptic drug available treatment partial onset seizure patient epilepsy . This study systematic review publish literature anti-epileptic drug design compare relative effectiveness tolerability selection retigabine . The drug choose comparison lacosamide , pregabalin , tiagabine , zonisamide eslicarbazepine . They choose belong new generation drug epilepsy ( retigabine ) similar license well publish data study conduct similar patient population similar method . GSK commission YHEC ( York Health Economic Consortium ) carry review analysis . YHEC identify relevant study international database . These study compare one choose anti-epileptic drug placebo . The result pool combined order summarize data individual drug well compare result different drug retigabine . Since none individual clinical study compare one active drug another , systematic review indirect comparison drug , use establish recognised methodology well understood limitation .</brief_summary>
	<brief_title>Systematic Review : Retigabine Adjunctive Therapy Partial Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Zonisamide</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Ezogabine</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Eslicarbazepine acetate</mesh_term>
	<criteria>Have participate study meet follow criterion : Be study retigabine , eslicarbazepine , lacosamide , zonisamide , pregabalin tiagabine adjuvant therapy , compare placebo another drug ; Be randomize , placebocontrolled , addon trial , parallel trial crossover trial data first treatment period could treat parallel study ; Have recruit patient drugresistant partial epilepsy ( i.e. , simple partial , complex partial , and/or secondarily generalise tonicclonic seizure control least 1 AEDs ) ; Have maintenance treatment period 8 week longer , prospective baseline minimum 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>